Dr Deborah Meyran completed her physician training in Paediatric oncology (2014) and PhD in cancer immunotherapy in 2021. She is an early career clinician scientist who presently works as a clinical fellow in the Children Cancer Centre at the Royal Children’s hospital (RCH). During her PhD at Peter MacCallum Cancer Centre (PeterMac), she developed the first platform for immune profiling of paediatric tumours in Australia in collaboration with the national Zero Childhood Cancer Program.  

She is involved in 7 different projects (as CI or AI) in immune profiling/immunotherapy of childhood cancers with PeterMac, the Children Cancer Institute (CCI) in Sydney, RCH and the Victorian Comprehensive Cancer Centre (VCCC). She currently leads the collaboration between PeterMac, RCH and CCI for the development of T cell-based immunotherapy with an emphasis on the generation of memory chimeric antigen receptor engineered T cells (CAR T cells) to treat paediatric cancers.  

Her career as a paediatric oncologist and her expertise in cancer immunotherapy have ranked her as a leader in the field of immunotherapy dedicated to children with cancer. As evidence of her international recognition and expertise, she received invitations to presentations at international and national conferences and received multiple awards: best oral presentations (French society of paediatric immuno-haematology in 2012, and PeterMac scientific retreat in the category early clinician researcher in 2022), Picchi Award for Excellence in Cancer Research that acknowledge the most talented PhD candidate in the VCCC (2020). She has built strong collaborations between Australia and top European labs to expand the scope of her research.